Tepezza hearing loss litigation — safety… | DrugsMonitor.com

Clinical summary and reported injury patterns for Tepezza hearing loss litigation. Links to FDA recalls and litigation overview. Not medical advice.

teprotumumab, thyroid eye disease, tinnitus, sensorineural hearing loss

Clinical context

据称，用于治疗甲状腺眼病的 Teprotumumab 会导致某些患者出现永久性听力损失和耳鸣。

Litigation context

伊利诺伊州北区 MDL No. 3079； 发现正在进行中。